FDA Panel Backs Peptide Compounding Amidst Record-Breaking Measles Outbreaks and Rising Foodborne Illness Concerns
The landscape of American public health is currently navigating a complex intersection of regulatory shifts,...
The landscape of American public health is currently navigating a complex intersection of regulatory shifts,...
The leadership carousel in the biotechnology sector continues to spin at a rapid clip, and...
The rapid escalation of cases in 2026 has officially made this the nation’s most severe...
In a landmark two-day session that may signal a paradigm shift in American drug regulation,...
As the United States grapples with a record-breaking surge in foodborne illness, the intersection of...
Amid intensifying national debates over whether the political influence of the "Make America Healthy Again"...
In a move that signals a significant shift in the global strategy to eradicate the...
In a landmark decision that signals a profound shift in the American regulatory landscape, an...
The most immediate concern for millions of patients living with diabetes is the announcement of...
The transition of executive leadership within the biotechnology sector often serves as a bellwether for...